E-Mail
The first clinical trial of a new dietary treatment for children and adults with severe forms of epilepsy, co-developed by UCL researchers and based on the ketogenic diet, has been successfully completed.
For the study, published in
Brain Communications, clinicians evaluated the use of K.Vita®, (also known as Betashot), an oral liquid dietary supplement developed by UCL in collaboration with Royal Holloway, University of London, and Vitaflo International Ltd.
The ketogenic diet (KD) consists of high-fat, low-carbohydrate and adequate protein consumption and mimics the fasting state, altering the metabolism to use body fat as the primary fuel source. This switch from carbohydrates to fat for body fuel is known as ketosis.
New dietary treatment for epilepsy well tolerated and reduced seizures – study
New dietary treatment for epilepsy well tolerated and reduced seizures – study (David Davies/PA)
A new dietary treatment for epilepsy based on a high fat, low carbohydrate diet was well tolerated and reduced seizures, study results have suggested.
The first clinical trial of a new oral liquid supplement for children and adults with severe forms of the condition is based on the ketogenic diet (KD).
It consists of high-fat, low-carbohydrate and adequate protein consumption and mimics fasting, altering the metabolism to use body fat as the primary fuel source.
More Evidence Ties Hearing Loss to Increased Dementia Risk medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.